Litigation Details for Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-05-09 |
| Court | District Court, D. Delaware | Date Terminated | 2018-12-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 7,709,517; 8,183,274; 9,126,941 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Pharma Inc. v. Roxane Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-05-09 | 1 | United States Patent Nos. 7,709,517 (“the ’517 patent”), 8,183,274 (“the ’274 patent”), and 9,126,941…infringed one or more claims of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941 by submitting…infringe one or more claims of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941 under 35 U.S.C…to the expiration dates of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941, inclusive of… the expiration dates of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941, inclusive of | External link to document | |
| 2017-05-09 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2; 8,183,274 B2; 9,126,941…2017 7 December 2018 1:17-cv-00542 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
